How promising are the latest monoclonal antibodies targeting amyloid-β for the treatment of early Alzheimer’s disease?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

How promising are the latest monoclonal antibodies targeting amyloid-β for the treatment of early Alzheimer’s disease?

Published:2024-01-02 Issue:1 Volume:29 Page:35-43
ISSN:1472-8214
Container-title:Expert Opinion on Emerging Drugs
language:en
Short-container-title:Expert Opinion on Emerging Drugs

Author:

Beveridge Jordan¹,Kaniecki Eileen¹,Naidu Aniketh¹,Silverglate Bret David¹,Grossberg George¹

Affiliation:

1. Saint Louis University School of Medicine, Department of Psychiatry and Behavioral Neuroscience, Division of Geriatric Psychiatry, St. Louis, MO, USA

Funder

Fundação para a Ciência e a Tecnologia

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/14728214.2024.2304059

Reference41 articles.

1. Monoclonal antibodies inhibit in vitro fibrillar aggregation of the Alzheimer beta-amyloid peptide.

2. Kumar A Tsao JW Alzheimer disease [internet]. Nih.Gov. StatPearls Publishing. 2019 [cited 2023 Sep 27]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK499922/

3. Randomised controlled trials for the prevention of cognitive decline or dementia: A systematic review

4. Amyloid‐β PET in Alzheimer's disease: A systematic review and Bayesian meta‐analysis

5. Emerging blood exosome-based biomarkers for preclinical and clinical Alzheimer’s disease: a meta-analysis and systematic review

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP